ArticleBritish journal of haematology2025

Polatuzumab vedotin and CD79B: A study of efficacy in R-CHOP-resistant diffuse large B-cell lymphoma.

Nicolas Munz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.